Cargando…
Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses
PURPOSE: Oral metronidazole therapy is the standard of care for bacterial vaginosis (BV), yet it has alarming rates of recurrence and refractory responses among recurrent BV (RBV) patients. This study addresses whether high dose vaginal metronidazole therapy (HDM) is beneficial in RBV patients who f...
Autores principales: | Sobel, Jack D, Kaur, Navkiranjot, Woznicki, Nicole A, Boikov, Dina, Aguin, Tina, Gill, Gurveer, Akins, Robert A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661983/ https://www.ncbi.nlm.nih.gov/pubmed/31413606 http://dx.doi.org/10.2147/IDR.S213853 |
Ejemplares similares
-
Association of key species of vaginal bacteria of recurrent bacterial vaginosis patients before and after oral metronidazole therapy with short- and long-term clinical outcomes
por: Mollin, Ashomathi, et al.
Publicado: (2022) -
Effect of metronidazole on vaginal microbiota associated with asymptomatic bacterial vaginosis
por: Ruiz-Perez, Daniel, et al.
Publicado: (2021) -
Longitudinal Analysis of Vaginal Microbiome Dynamics in Women with Recurrent Bacterial Vaginosis: Recognition of the Conversion Process
por: Lambert, Janet A., et al.
Publicado: (2013) -
Comparative Study of Intravaginal Metronidazole and Triple-Sulfa Therapy for Bacterial Vaginosis
por: Sobel, Jack D., et al.
Publicado: (1996) -
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis
por: Schwebke, Jane R., et al.
Publicado: (2015)